# PDS Biotechnology (PDSB) — Earnings

PDSB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pdsb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.18 |
| EPS estimate | −$0.13 |
| EPS surprise | −38.46% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1472091/000114036126032824/ef20075210_10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.13 | −$0.18 | -38.46% | — | — |
| Q1 2026 | May 13, 2026 | −$0.14 | −$0.13 | 7.14% | — | — |
| Q4 2025 | Mar 30, 2026 | −$0.20 | −$0.13 | 35.00% | — | — |
| Q3 2025 | Nov 13, 2025 | −$0.20 | −$0.19 | 3.41% | — | — |
| Q2 2025 | Aug 13, 2025 | −$0.23 | −$0.21 | 9.99% | — | — |
| Q1 2025 | May 14, 2025 | −$0.25 | −$0.21 | 14.88% | — | — |
| Q4 2024 | Mar 27, 2025 | −$0.28 | −$0.21 | 24.11% | — | — |
| Q3 2024 | Nov 14, 2024 | −$0.30 | −$0.29 | 2.26% | — | — |
| Q2 2024 | Aug 13, 2024 | −$0.33 | −$0.23 | 29.60% | — | — |
| Q1 2024 | May 15, 2024 | −$0.37 | −$0.30 | 18.19% | — | — |
| Q4 2023 | Mar 27, 2024 | −$0.44 | −$0.35 | 20.20% | — | — |
| Q3 2023 | Nov 14, 2023 | −$0.45 | −$0.35 | 21.47% | — | — |
| Q2 2023 | Aug 14, 2023 | −$0.35 | −$0.37 | -6.60% | — | — |
| Q1 2023 | May 15, 2023 | −$0.30 | −$0.32 | -6.67% | — | — |
| Q4 2022 | Mar 28, 2023 | −$0.29 | −$0.65 | -126.40% | — | — |
| Q3 2022 | Nov 14, 2022 | −$0.28 | −$0.26 | 7.60% | — | — |
| Q2 2022 | Aug 8, 2022 | −$0.28 | −$0.20 | 29.00% | — | — |
| Q1 2022 | May 11, 2022 | −$0.23 | −$0.32 | -38.11% | — | — |
| Q4 2021 | Mar 31, 2022 | −$0.24 | −$0.25 | -3.43% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.21 | −$0.24 | -17.07% | — | — |

## Frequently Asked Questions

### When did PDS Biotechnology (PDSB) last report earnings?

PDS Biotechnology last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did PDSB beat earnings estimates?

No. PDS Biotechnology reported EPS of −$0.18 for Q2 2026 against a −$0.13 estimate — a 38.46% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).